Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,293 publicly listed stocks with a combined market cap of $2.10 Trillion. Tenax Therapeutics Inc leads the sector with a market cap of $68.49 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$2.10 Trillion
Companies Listed
1,293
Largest Company
Tenax Therapeutics Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 751 |
Tenax Therapeutics Inc
NASDAQ:TENX |
$68.49 Million | $68.49 Million | USA | $1.83 | -1.61% | -5.67% | 167.55 Million |
| 752 |
Coeptis Therapeutics Inc
NASDAQ:COEP |
$68.21 Million | $68.21 Million | USA | $16.40 | +1.17% | +19.62% | 1.29 Million |
| 753 |
Yarrow Bioscience Inc
NASDAQ:YARW |
$68.08 Million | $68.08 Million | USA | $25.50 | -2.89% | -15.59% | 2.33 Million |
| 754 |
LeonaBio, Inc.
NASDAQ:LONA |
$68.01 Million | $68.01 Million | USA | $7.24 | -3.08% | -4.23% | 1.59 Million |
| 755 |
XBiotech Inc
NASDAQ:XBIT |
$66.92 Million | $66.92 Million | USA | $2.20 | +1.15% | -0.23% | 1.18 Million |
| 756 |
Oncopeptides AB
ST:ONCO |
$66.65 Million | Skr619.37 Million | Sweden | Skr1.63 | +0.31% | -6.98% | 82.79 Million |
| 757 |
Champions Oncology Inc
NASDAQ:CSBR |
$66.24 Million | $66.24 Million | USA | $4.77 | -3.05% | -8.62% | 248.88K |
| 758 |
Spero Therapeutics Inc
NASDAQ:SPRO |
$65.43 Million | $65.43 Million | USA | $1.13 | -0.88% | -6.61% | 10.48 Million |
| 759 |
Alterity Therapeutics Limited
F:PBN |
$65.25 Million | €55.81 Million | Germany | €0.25 | -13.10% | -14.29% | 10.00K |
| 760 |
Kazia Therapeutics Ltd ADR
NASDAQ:KZIA |
$64.84 Million | $64.84 Million | USA | $11.82 | +2.52% | +18.20% | 5.85 Million |
| 761 |
Entera Bio Ltd
NASDAQ:ENTX |
$64.20 Million | $64.20 Million | USA | $2.86 | +1.42% | -4.67% | 8.64 Million |
| 762 |
Alterity Therapeutics Ltd
NASDAQ:ATHE |
$63.73 Million | $63.73 Million | USA | $3.50 | -9.33% | -22.91% | 505.33K |
| 763 |
Cingulate Inc
NASDAQ:CING |
$62.60 Million | $62.60 Million | USA | $5.11 | -1.16% | +0.20% | 3.19 Million |
| 764 |
iNtRON Biotechnology Inc
KQ:048530 |
$61.27 Million | ₩90.42 Billion | Korea | ₩2860.00 | -1.38% | -0.35% | 1.92 Million |
| 765 |
Oncoinvent ASA
OL:ONCIN |
$60.79 Million | Nkr577.72 Million | Norway | Nkr129.00 | -8.83% | +29.00% | 396.40K |
| 766 |
Mink Therapeutics Inc
NASDAQ:INKT |
$60.73 Million | $60.73 Million | USA | $11.97 | -0.25% | +5.65% | 298.68K |
| 767 |
Rein Therapeutics Inc
NASDAQ:RNTX |
$60.52 Million | $60.52 Million | USA | $0.71 | -10.56% | -20.42% | 11.57 Million |
| 768 |
Synthaverse S.A.
WAR:SVE |
$60.37 Million | zł219.36 Million | Poland | zł2.90 | +0.87% | -4.14% | 982.96K |
| 769 |
Ikena Oncology Inc
NASDAQ:IKNA |
$59.90 Million | $59.90 Million | USA | $1.43 | +0.00% | +0.00% | 457.26K |
| 770 |
OKYO Pharma Ltd ADR
NASDAQ:OKYO |
$59.80 Million | $59.80 Million | USA | $1.59 | -1.85% | -3.64% | 2.23 Million |
| 771 |
Heron Therapeuti
NASDAQ:HRTX |
$59.43 Million | $59.43 Million | USA | $0.31 | -0.41% | -8.69% | 51.47 Million |
| 772 |
Xilio Development Inc
NASDAQ:XLO |
$59.02 Million | $59.02 Million | USA | $9.03 | +1.12% | +0.33% | 263.02K |
| 773 |
NRX Pharmaceuticals Inc
NASDAQ:NRXP |
$58.91 Million | $58.91 Million | USA | $3.40 | -2.58% | -2.58% | 18.18 Million |
| 774 |
ONDINE BIOMEDICAL INC.CDI
F:VF5 |
$58.62 Million | €50.14 Million | Germany | €0.10 | -1.03% | -9.81% | 0.00 |
| 775 |
EyeGene Inc
KQ:185490 |
$58.58 Million | ₩86.45 Billion | Korea | ₩2000.00 | -0.50% | -0.99% | 5.41 Million |
| 776 |
Fluoguide AS
ST:FLUO |
$58.41 Million | Skr542.80 Million | Sweden | Skr33.20 | -1.48% | -7.00% | 99.99K |
| 777 |
Cassava Sciences Inc
NASDAQ:SAVA |
$58.21 Million | $58.21 Million | USA | $1.21 | -6.23% | -20.98% | 10.03 Million |
| 778 |
LTR Pharma Ltd
AU:LTP |
$57.88 Million | AU$81.80 Million | Australia | AU$0.45 | -1.10% | -11.76% | 3.06 Million |
| 779 |
INmune Bio Inc
NASDAQ:INMB |
$57.87 Million | $57.87 Million | USA | $2.26 | -3.00% | -7.38% | 7.80 Million |
| 780 |
Eloxx Pharmaceuticals, Inc.
NASDAQ:ELOX |
$56.94 Million | $56.94 Million | USA | $18.25 | +11.96% | +21.67% | 481.88K |
| 781 |
ImageneBio, Inc.
NASDAQ:IMA |
$55.96 Million | $55.96 Million | USA | $4.92 | -1.60% | +1.44% | 301.37K |
| 782 |
eXoZymes, Inc.
NASDAQ:EXOZ |
$55.75 Million | $55.75 Million | USA | $6.58 | +4.70% | -4.01% | 130.92K |
| 783 |
Bonus Biogroup
TA:BONS |
$55.11 Million | ILA20.56 Billion | Israel | ILA17.60 | +0.57% | -2.76% | 45.79 Million |
| 784 |
Dogwood Therapeutics, Inc.
NASDAQ:DWTX |
$54.85 Million | $54.85 Million | USA | $1.85 | -4.90% | -25.60% | 1.82 Million |
| 785 |
Theranexus SA
PA:ALTHX |
$54.70 Million | €46.79 Million | France | €3.24 | -2.99% | -15.40% | 2.40 Million |
| 786 |
Avecho Biotechnology Ltd
AU:AVE |
$54.68 Million | AU$77.27 Million | Australia | AU$0.02 | -4.76% | +5.26% | 86.20 Million |
| 787 |
ImmunoPrecise Antibodies Ltd.
NASDAQ:HYFT |
$53.93 Million | $53.93 Million | USA | $1.16 | -13.16% | -12.50% | 3.27 Million |
| 788 |
FLUOGUIDE A/S DK -1
F:96X |
$53.90 Million | €46.11 Million | Germany | €2.82 | -2.08% | -8.74% | 0.00 |
| 789 |
Kronos Bio Inc
NASDAQ:KRON |
$53.65 Million | $53.65 Million | USA | $0.88 | +0.00% | +0.00% | 54.09K |
| 790 |
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV |
$52.70 Million | $52.70 Million | USA | $1.83 | -6.63% | -14.08% | 8.33 Million |
| 791 |
Elicio Therapeutics Inc.
NASDAQ:ELTX |
$52.56 Million | $52.56 Million | USA | $2.00 | -2.44% | -21.57% | 7.31 Million |
| 792 |
Ultimovacs ASA
OL:ULTI |
$52.14 Million | Nkr495.45 Million | Norway | Nkr14.40 | +0.00% | +0.00% | 8.70K |
| 793 |
Hyperion DeFi, Inc.
NASDAQ:HYPD |
$51.12 Million | $51.12 Million | USA | $3.29 | -9.62% | -0.30% | 15.24 Million |
| 794 |
Klotho Neurosciences, Inc.
NASDAQ:KLTO |
$50.59 Million | $50.59 Million | USA | $0.47 | -10.72% | +13.43% | 161.05 Million |
| 795 |
Arovella Therapeutics Ltd
AU:ALA |
$50.46 Million | AU$71.32 Million | Australia | AU$0.06 | -1.67% | -6.35% | 12.17 Million |
| 796 |
Naturalendo Tech Co Ltd
KQ:168330 |
$49.53 Million | ₩73.09 Billion | Korea | ₩2315.00 | +2.43% | +6.19% | 331.25K |
| 797 |
CTCBIO Inc
KQ:060590 |
$49.34 Million | ₩72.80 Billion | Korea | ₩3045.00 | +0.83% | -2.72% | 987.21K |
| 798 |
Prescient Therapeutics Ltd
AU:PTX |
$49.10 Million | AU$69.40 Million | Australia | AU$0.07 | +1.54% | -2.94% | 27.53 Million |
| 799 |
Instil Bio Inc.
NASDAQ:TIL |
$48.90 Million | $48.90 Million | USA | $7.21 | -3.22% | -4.88% | 230.80K |
| 800 |
Mereo BioPharma Group PLC ADR
NASDAQ:MREO |
$48.79 Million | $48.79 Million | USA | $0.31 | -4.60% | -9.50% | 37.78 Million |
| 801 |
Bluebird bio Inc
NASDAQ:BLUE |
$48.67 Million | $48.67 Million | USA | $4.97 | +0.00% | +0.00% | 1.25 Million |
| 802 |
Tevogen Bio Holdings Inc.
NASDAQ:TVGN |
$47.79 Million | $47.79 Million | USA | $7.75 | +3.20% | +5.59% | 201.03K |
| 803 |
Annovis Bio Inc
NYSE:ANVS |
$47.65 Million | $47.65 Million | USA | $1.12 | -1.75% | -19.42% | 26.32 Million |
| 804 |
Entropy Neurodynamics Limited
AU:ENP |
$47.39 Million | AU$66.98 Million | Australia | AU$0.04 | +0.00% | -2.38% | 43.14 Million |
| 805 |
XSpray Pharma AB
ST:XSPRAY |
$47.35 Million | Skr440.03 Million | Sweden | Skr9.28 | -0.75% | -7.39% | 4.34 Million |
| 806 |
Werewolf Therapeutics Inc
NASDAQ:HOWL |
$46.90 Million | $46.90 Million | USA | $0.98 | +2.31% | +1.45% | 390.29 Million |
| 807 |
PENTIXAPHARM HOLDING N AG
XETRA:PTP |
$46.89 Million | €40.11 Million | Germany | €1.90 | -0.52% | -0.26% | 510.77K |
| 808 |
Immutep Ltd
AU:IMM |
$46.87 Million | AU$66.24 Million | Australia | AU$0.05 | -4.26% | -2.17% | 195.23 Million |
| 809 |
IGM Biosciences Inc
NASDAQ:IGMS |
$46.47 Million | $46.47 Million | USA | $1.27 | +0.00% | +0.00% | 1.62 Million |
| 810 |
Seres Therapeutics Inc
NASDAQ:MCRB |
$46.21 Million | $46.21 Million | USA | $4.60 | -2.75% | -19.58% | 1.35 Million |
| 811 |
LAVA Therapeutics NV
NASDAQ:LVTX |
$45.77 Million | $45.77 Million | USA | $1.74 | +0.00% | -3.87% | 2.49 Million |
| 812 |
Impact BioMedical, Inc.
NYSE MKT:IBO |
$45.54 Million | $45.54 Million | USA | $0.44 | +0.07% | +4.89% | 1.10 Million |
| 813 |
Cellid Co. Ltd
KQ:299660 |
$45.19 Million | ₩66.68 Billion | Korea | ₩2260.00 | -2.59% | -5.24% | 55.50 Million |
| 814 |
Immutep Limited
F:YP1A |
$45.10 Million | €38.57 Million | Germany | €0.26 | -7.69% | -14.84% | 0.00 |
| 815 |
Mendus AB (publ)
ST:IMMU |
$43.79 Million | Skr406.92 Million | Sweden | Skr6.64 | -3.35% | -9.04% | 662.00K |
| 816 |
Arch Biopartners Inc
V:ARCH |
$43.74 Million | CA$60.46 Million | Canada | CA$0.89 | -4.30% | -12.75% | 1.52 Million |
| 817 |
Raphas Co. Ltd
KQ:214260 |
$43.71 Million | ₩64.49 Billion | Korea | ₩7670.00 | +2.13% | -3.52% | 393.53K |
| 818 |
Herantis Pharma Oyj
HE:HRTIS |
$43.69 Million | €37.37 Million | Finland | €1.41 | -1.40% | -9.62% | 680.10K |
| 819 |
Amplia Therapeutics Ltd
AU:ATX |
$43.58 Million | AU$61.60 Million | Australia | AU$0.12 | +0.00% | -7.69% | 15.65 Million |
| 820 |
Metagenomi, Inc. Common Stock
NASDAQ:MGX |
$43.44 Million | $43.44 Million | USA | $1.16 | -2.52% | -0.85% | 3.90 Million |
| 821 |
Molecure S.A.
WAR:MOC |
$43.26 Million | zł157.20 Million | Poland | zł7.63 | +3.39% | +19.41% | 1.03 Million |
| 822 |
OS Therapies Incorporated
NYSE MKT:OSTX |
$42.96 Million | $42.96 Million | USA | $1.73 | -4.95% | -7.98% | 19.37 Million |
| 823 |
Corline Biomedical AB
ST:CLBIO |
$42.75 Million | Skr397.22 Million | Sweden | Skr15.20 | -3.18% | -6.17% | 305.91K |
| 824 |
GenMont Biotech Inc
TW:3164 |
$42.54 Million | NT$1.35 Billion | Taiwan | NT$15.70 | -0.32% | -1.26% | 536.13K |
| 825 |
Cantargia AB
ST:CANTA |
$42.27 Million | Skr392.81 Million | Sweden | Skr1.58 | -0.69% | -8.67% | 26.98 Million |
| 826 |
SMS Lifesciences India Limited
NSE:SMSLIFE |
$42.13 Million | Rs3.90 Billion | India | Rs1288.50 | -6.64% | -3.37% | 65.05K |
| 827 |
PanGen Biotech Inc
KQ:222110 |
$42.07 Million | ₩62.07 Billion | Korea | ₩4600.00 | -3.56% | -7.91% | 192.76K |
| 828 |
Lite Strategy, Inc.
NASDAQ:LITS |
$40.08 Million | $40.08 Million | USA | $1.09 | -5.22% | -4.39% | 6.93 Million |
| 829 |
CORESTEM Inc
KQ:166480 |
$39.89 Million | ₩58.86 Billion | Korea | ₩2095.00 | -0.95% | -4.12% | 2.28 Million |
| 830 |
Edesa Biotech Inc
NASDAQ:EDSA |
$39.72 Million | $39.72 Million | USA | $4.12 | -0.36% | -12.90% | 1.90 Million |
| 831 |
Biomind Labs Inc
NEO:BMND |
$38.72 Million | CA$53.52 Million | Canada | CA$0.69 | +0.00% | +193.62% | 107.88K |
| 832 |
Abnova Taiwan Corp
TW:4133 |
$38.54 Million | NT$1.22 Billion | Taiwan | NT$20.20 | +0.00% | -1.46% | 1.55 Million |
| 833 |
LAVA THERAP. B.V. EO-12
F:4PKB |
$38.54 Million | €32.96 Million | Germany | €1.44 | -6.49% | +5.88% | 28.80K |
| 834 |
OKYO PHARMA LTD SP.ADR/65
F:OK10 |
$38.38 Million | €32.83 Million | Germany | €1.36 | +0.00% | +0.00% | 0.00 |
| 835 |
aTyr Pharma, Inc.
NASDAQ:ATYR |
$38.16 Million | $38.16 Million | USA | $0.39 | +0.15% | -21.69% | 17.75 Million |
| 836 |
Vivoryon Therapeutics NV
AS:VVY |
$37.91 Million | €32.42 Million | Netherlands | €1.10 | -1.35% | -2.65% | 434.46K |
| 837 |
FibroGen Inc
NASDAQ:FGEN |
$37.30 Million | $37.30 Million | USA | $9.22 | -5.05% | +5.98% | 925.11K |
| 838 |
CervoMed Inc.
NASDAQ:CRVO |
$37.04 Million | $37.04 Million | USA | $2.45 | -3.16% | -4.30% | 5.86 Million |
| 839 |
Actinium Pharmaceuticals Inc
NYSE MKT:ATNM |
$37.02 Million | $37.02 Million | USA | $1.18 | +0.00% | -7.81% | 4.49 Million |
| 840 |
Intervacc AB
ST:IVACC |
$36.82 Million | Skr342.18 Million | Sweden | Skr1.00 | +3.83% | -5.99% | 6.89 Million |
| 841 |
Veru Inc
NASDAQ:VERU |
$36.76 Million | $36.76 Million | USA | $2.34 | +0.00% | -11.36% | 5.14 Million |
| 842 |
Relief Therapeutics Holding AG
SW:RLF |
$36.33 Million | CHF28.73 Million | Switzerland | CHF2.89 | +0.87% | +3.41% | 379.74K |
| 843 |
OUTLOOK THERAPEUTICS INC
NASDAQ:OTLK |
$36.02 Million | $36.02 Million | USA | $0.67 | +5.50% | +0.90% | 454.52 Million |
| 844 |
Generation Bio Co
NASDAQ:GBIO |
$35.98 Million | $35.98 Million | USA | $5.34 | -6.97% | -4.81% | 2.86 Million |
| 845 |
Celularity Inc
NASDAQ:CELU |
$35.76 Million | $35.76 Million | USA | $1.24 | -11.43% | -26.19% | 245.21 Million |
| 846 |
NUREXONE BIOLOGIC INC.
F:J90 |
$35.72 Million | €30.55 Million | Germany | €0.38 | +7.63% | -6.85% | 139.95K |
| 847 |
MedMira Inc
V:MIR |
$35.53 Million | CA$49.12 Million | Canada | CA$0.07 | +7.69% | +0.00% | 2.46 Million |
| 848 |
Mural Oncology plc
NASDAQ:MURA |
$35.38 Million | $35.38 Million | USA | $2.04 | +0.00% | +0.49% | 4.99 Million |
| 849 |
Atara Biotherapeutics Inc
NASDAQ:ATRA |
$35.19 Million | $35.19 Million | USA | $9.44 | +2.05% | -3.28% | 1.27 Million |
| 850 |
Mabion S.A.
WAR:MAB |
$35.18 Million | zł127.84 Million | Poland | zł7.91 | -1.12% | -2.22% | 1.02 Million |
| 851 |
Karyopharm Therapeutics Inc
NASDAQ:KPTI |
$34.90 Million | $34.90 Million | USA | $1.54 | -3.75% | -13.97% | 31.89 Million |
| 852 |
Grace Therapeutics, Inc.
NASDAQ:GRCE |
$34.51 Million | $34.51 Million | USA | $2.23 | -2.62% | +6.19% | 3.73 Million |
| 853 |
DNA Biomed Solns
TA:DNA |
$33.68 Million | ILA12.56 Billion | Israel | ILA102.00 | -2.02% | -4.49% | 1.25 Million |
| 854 |
Filana Therapeutics, Inc.
NASDAQ:FLNA |
$33.65 Million | $33.65 Million | USA | $0.70 | -3.10% | -15.06% | 6.17 Million |
| 855 |
Context Therapeutics Inc
NASDAQ:CNTX |
$33.48 Million | $33.48 Million | USA | $0.36 | +3.82% | +0.66% | 44.91 Million |
| 856 |
GeneOne Life Science Inc
KO:011000 |
$32.81 Million | ₩48.42 Billion | Korea | ₩2670.00 | +0.00% | +216.73% | 98.20 Million |
| 857 |
Lipum AB
ST:LIPUM |
$32.76 Million | Skr304.40 Million | Sweden | Skr14.35 | +0.70% | +1.77% | 1.28 Million |
| 858 |
Level Biotechnology
TWO:3118 |
$32.36 Million | NT$1.03 Billion | Taiwan | NT$31.65 | +0.16% | +0.80% | 445.24K |
| 859 |
NovaBay Pharmaceuticals Inc
NYSE MKT:NBY |
$32.22 Million | $32.22 Million | USA | $1.21 | +4.31% | -13.57% | 3.36 Million |
| 860 |
SoftOx Solutions AS
OL:SOFTX |
$32.13 Million | Nkr305.36 Million | Norway | Nkr0.11 | +6.30% | +9.96% | 424.43 Million |
| 861 |
Mereo BioPharma Group plc
F:MAH0 |
$31.92 Million | €27.31 Million | Germany | €0.24 | +0.00% | +13.46% | 10.00K |
| 862 |
MINDMAZE THERAPEUTICS HOLDING SA
SW:MMTX |
$31.84 Million | CHF25.18 Million | Switzerland | CHF0.16 | -1.96% | -1.72% | 29.98 Million |
| 863 |
Sprint Bioscience AB
ST:SPRINT |
$31.57 Million | Skr293.33 Million | Sweden | Skr2.78 | +1.46% | -14.20% | 8.26 Million |
| 864 |
Lyka Labs Limited
NSE:LYKALABS |
$31.36 Million | Rs2.90 Billion | India | Rs81.25 | -1.99% | +3.69% | 399.99K |
| 865 |
Genoway
PA:ALGEN |
$31.09 Million | €26.60 Million | France | €2.38 | -2.46% | -4.03% | 44.56K |
| 866 |
BeyondSpring Inc
NASDAQ:BYSI |
$30.86 Million | $30.86 Million | USA | $0.75 | -1.25% | +21.44% | 41.43 Million |
| 867 |
Microbix Biosystems Inc.
TO:MBX |
$30.83 Million | CA$42.63 Million | Canada | CA$0.31 | +0.00% | +3.33% | 828.35K |
| 868 |
RTA Laboratuvarlari Biyolojik
IS:RTALB |
$30.68 Million | TL1.37 Billion | Turkey | TL2.74 | -9.57% | -1.44% | 419.63 Million |
| 869 |
Jiangsu Wuzhong Industrial Co Ltd
SHG:600200 |
$30.17 Million | CN¥206.16 Million | China | CN¥0.29 | +0.00% | -9.38% | 993.60 Million |
| 870 |
Apollomics Inc. Class A Ordinary Shares
NASDAQ:APLM |
$30.09 Million | $30.09 Million | USA | $24.02 | +3.62% | -12.64% | 289.49K |
| 871 |
Briacell Therapeutics Corp
NASDAQ:BCTX |
$30.01 Million | $30.01 Million | USA | $3.58 | +0.56% | +0.28% | 12.46 Million |
| 872 |
Allakos Inc
NASDAQ:ALLK |
$29.74 Million | $29.74 Million | USA | $0.33 | +0.00% | +0.00% | 725.84K |
| 873 |
Karolinska Development AB ser. B
ST:KDEV |
$29.36 Million | Skr272.85 Million | Sweden | Skr0.29 | +0.00% | +0.00% | 14.10 Million |
| 874 |
Quince Therapeutics, Inc.
NASDAQ:QNCX |
$29.34 Million | $29.34 Million | USA | $28.85 | +0.89% | -7.90% | 511.77K |
| 875 |
Take Solutions Limited
NSE:TAKE |
$29.24 Million | Rs2.70 Billion | India | Rs18.49 | +5.00% | +33.79% | 9.90 Million |
| 876 |
NextCure Inc
NASDAQ:NXTC |
$29.16 Million | $29.16 Million | USA | $6.37 | -4.07% | -18.54% | 3.31 Million |
| 877 |
Barinthus Biotherapeutics plc
NASDAQ:BRNS |
$28.99 Million | $28.99 Million | USA | $0.74 | +0.00% | +2.86% | 1.58 Million |
| 878 |
GeneReach Biotechnology
TWO:4171 |
$28.93 Million | NT$918.25 Million | Taiwan | NT$16.15 | +0.00% | -3.87% | 1.42 Million |
| 879 |
Kyntra Bio, Inc.
NASDAQ:KYNB |
$28.74 Million | $28.74 Million | USA | $7.77 | -3.24% | -9.12% | 515.98K |
| 880 |
ABVC Biopharma Inc
NASDAQ:ABVC |
$28.25 Million | $28.25 Million | USA | $1.07 | +7.00% | +11.46% | 2.89 Million |
| 881 |
PolTREG S.A.
WAR:PTG |
$28.11 Million | zł102.13 Million | Poland | zł21.90 | -4.37% | -1.35% | 120.21K |
| 882 |
ProMIS Neurosciences Inc.
NASDAQ:PMN |
$27.75 Million | $27.75 Million | USA | $12.89 | -2.79% | +2.30% | 871.39K |
| 883 |
Evaxion Biotech AS
NASDAQ:EVAX |
$27.70 Million | $27.70 Million | USA | $3.07 | -1.92% | +0.00% | 11.24 Million |
| 884 |
Sangamo Therapeutics Inc
NASDAQ:SGMO |
$27.50 Million | $27.50 Million | USA | $0.07 | +0.00% | +0.00% | 83.11 Million |
| 885 |
India Globalization Capital Inc
NYSE MKT:IGC |
$26.91 Million | $26.91 Million | USA | $0.29 | +0.38% | -3.01% | 21.20 Million |
| 886 |
Aligos Therapeutics Inc
NASDAQ:ALGS |
$26.89 Million | $26.89 Million | USA | $4.99 | -0.99% | -19.65% | 1.57 Million |
| 887 |
Athira Pharma Inc
NASDAQ:ATHA |
$26.62 Million | $26.62 Million | USA | $7.66 | +10.85% | +25.78% | 1.34 Million |
| 888 |
Estrella Immunopharma Inc.
NASDAQ:ESLA |
$26.58 Million | $26.58 Million | USA | $0.61 | -3.86% | -5.42% | 798.89K |
| 889 |
Cue Biopharma
NASDAQ:CUE |
$26.56 Million | $26.56 Million | USA | $31.64 | +3.57% | +15.31% | 4.00 Million |
| 890 |
Botanix Pharmaceuticals Ltd
AU:BOT |
$26.49 Million | AU$37.44 Million | Australia | AU$0.02 | +0.00% | -9.52% | 143.07 Million |
| 891 |
Plus Therapeutics Inc
NASDAQ:PSTV |
$26.42 Million | $26.42 Million | USA | $3.84 | +1.80% | +5.15% | 2.61 Million |
| 892 |
Renovaro Biosciences Inc
NASDAQ:RENB |
$26.19 Million | $26.19 Million | USA | $1.13 | -8.87% | -20.42% | 55.28 Million |
| 893 |
LakeShore Biopharma Co., Ltd
NASDAQ:LSB |
$25.84 Million | $25.84 Million | USA | $0.63 | +0.00% | -26.63% | 93.54K |
| 894 |
Avecho Biotechnology Limited
F:OEZ |
$25.76 Million | €22.04 Million | Germany | €0.01 | +0.00% | +16.67% | 0.00 |
| 895 |
Boundless Bio, Inc. Common Stock
NASDAQ:BOLD |
$25.63 Million | $25.63 Million | USA | $2.81 | -1.06% | -2.09% | 2.50 Million |
| 896 |
iBio, Inc. Common Stock
NYSE MKT:IBIO |
$24.96 Million | $24.96 Million | USA | $1.20 | -6.25% | +0.00% | 31.77 Million |
| 897 |
Radiopharm Theranostics Ltd
AU:RAD |
$24.55 Million | AU$34.70 Million | Australia | AU$0.01 | -11.11% | -20.00% | 294.06 Million |
| 898 |
Seoulin Bioscience Co.Ltd
KQ:038070 |
$24.29 Million | ₩35.84 Billion | Korea | ₩4060.00 | +1.00% | -4.36% | 707.30K |
| 899 |
Medicenna Therapeutics Corp
TO:MDNA |
$24.14 Million | CA$33.37 Million | Canada | CA$0.40 | -4.76% | -14.89% | 1.20 Million |
| 900 |
Kainos Medicine Inc
KQ:284620 |
$24.10 Million | ₩35.56 Billion | Korea | ₩1087.00 | +0.00% | +0.00% | 883.91K |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries